LONDON, May 16, 2014 /PRNewswire/ --
The US markets saw a negative sentiment on Thursday, May 15, 2014, with the NASDAQ Composite closing at 4,069.29, down 0.76%, the Dow Jones Industrial Average ending the session at 16,446.81, down 1.01% and the S&P 500 finishing 0.94% lower at 1,870.85. The losses were broad based as nine out of ten sectors finished on a lower note. A number of stocks saw large movements, including Kindred Healthcare Inc. (NYSE: KND), StemCells Inc. (NASDAQ: STEM), Miller Energy Resources Inc. (NYSE: MILL) and Amedisys Inc. (NASDAQ: AMED). Free technical research on KND, STEM, MILL and AMED can be downloaded upon signing up at:
http://www.investor-edge.com/2634-register
Kindred Healthcare Inc.'s stock fluctuated between $21.94 and $24.37 before ending the session 10.95% higher at $24.32. On Thursday, Kindred Healthcare Inc.'s stock reported a trading volume of 1.77 million shares, above its three months average volume of 0.55 million shares. Kindred Healthcare Inc.'s shares have surged 7.04% in the previous three trading sessions and 23.20% on YTD basis. However, the stock has lost 2.64% in the last one month. The stock is trading above its 50-day and 200-day moving averages of $23.53 and $18.40, respectively. Kindred Healthcare Inc.'s stock traded at a PE ratio of 33.02 and has a Relative Strength Index (RSI) of 35.92. On the same day, Kindred Healthcare Inc. announced a proposal to acquire all of the outstanding shares of common stock of Gentiva Health Services Inc. for a combination of $7.00 per share in cash and $7.00 of Kindred common stock. Sign up today to read free research on KND at:
http://www.investor-edge.com/2634-KND-16May2014.pdf
Shares in StemCells Inc. surged 9.68% on Thursday, closing the day at $1.36. The stock recorded a trading volume of 1.88 million shares, above its three months average volume of 0.68 million shares. The stock oscillated between $1.26 and $1.42 during the trading session. Shares in StemCells Inc. have gained 13.33% over the previous three trading sessions, 15.25% in the last one month and 10.57% since the start of this year. Shares of the company have an RSI of 46.51. On May 14, 2014, StemCells Inc. also announced its Q1 2014 financial results. The company reported that its revenue for Q1 FY2014 increased to $339,000, compared with revenue of 284,000, in the year-ago quarter. Sign up today to read free research on STEM at:
http://www.investor-edge.com/2634-STEM-16May2014.pdf
On Thursday, shares in Miller Energy Resources Inc. recorded a trading volume of 0.82 million shares, which was above its three months average volume of 0.51 million shares. The stock ended the day at $5.03, which was 6.12% above its previous day's closing, and registered an intraday range of $4.85 and $5.23. Miller Energy Resources Inc.'s shares have advanced 5.89% in the previous three trading sessions. However, the stock has fallen by 28.45% in the last three months and 28.55% on YTD basis. The S&P 500 Energy Sector Index mapped a loss of 1.31% during the trading session, and the index has fallen by 0.95% in the last three trading sessions. The company's stock is trading below its 50-day and 200-day moving averages of $5.48 and $6.59, respectively. Moreover, shares of the company have an RSI of 41.25. Sign up today to read free research on MILL at:
http://www.investor-edge.com/2634-MILL-16May2014.pdf
Shares in Amedisys Inc. finished Thursday's session 6.93% higher at $14.97. A total of 0.94 million shares were traded, above its three months average volume of 0.33 million shares. The stock moved between $14.30 and $15.15 during the session. Over the previous three trading sessions and in the last one month, Amedisys Inc.'s stock has gained 3.24% and 9.35%, respectively. Moreover, the stock has advanced 2.32% from the year's start. The S&P 500 Health Care Sector Index mapped a loss of 1.03% during the trading session, and the index has declined 0.51% in the previous three months. The company's shares are trading above their 50-day moving average. The stock's 50-day moving average of $14.43 is below its 200-day moving average of $15.64. Furthermore, Amedisys Inc.'s stock has an RSI of 50.01. Sign up today to read free research on AMED at:
http://www.investor-edge.com/2634-AMED-16May2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
